Ratings by Guggenheim (Vamil Divan)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/2/2026 | Merck | MRK | Maintain | Buy (Buy) |
|
Details | ||
| 6/1/2026 | Jade Biosciences | JBIO | Maintain | Buy (N/A) |
|
Details | ||
| 5/13/2026 | Unicycive Therapeutics | UNCY | Maintain | Buy (N/A) |
|
Details | ||
| 5/11/2026 | Jade Biosciences | JBIO | Maintain | Buy (N/A) |
|
Details | ||
| 5/8/2026 | Insmed | INSM | Maintain | Buy (N/A) |
|
Details | ||
| 5/4/2026 | Amgen | AMGN | Maintain | Neutral (N/A) |
|
Details | ||
| 4/27/2026 | Merck | MRK | Maintain | Buy (Buy) |
|
Details | ||
| 4/24/2026 | Travere Therapeutics | TVTX | Maintain | Buy (N/A) |
|
Details | ||
| 4/20/2026 | Johnson & Johnson | JNJ | Maintain | Buy (N/A) |
|
Details | ||
| 4/16/2026 | Insmed | INSM | Maintain | Buy (N/A) |
|
Details | ||
| 4/15/2026 | Johnson & Johnson | JNJ | Maintain | Buy (Buy) |
|
Details | ||
| 4/14/2026 | Travere Therapeutics | TVTX | Maintain | Buy (N/A) |
|
Details | ||
| 4/13/2026 | Pfizer | PFE | Maintain | Buy (Buy) |
|
Details | ||
| 4/10/2026 | Abbvie | ABBV | Maintain | Buy (N/A) |
|
Details | ||
| 4/9/2026 | Merck | MRK | Maintain | Buy (Buy) |
|
Details | ||
| 4/9/2026 | Amgen | AMGN | Maintain | Neutral (N/A) |
|
Details | ||
| 4/6/2026 | Assembly Biosciences | ASMB | Maintain | Buy (N/A) |
|
Details | ||
| 4/2/2026 | Unicycive Therapeutics | UNCY | Maintain | Buy (N/A) |
|
Details | ||
| 3/26/2026 | Merck | MRK | Maintain | Buy (Buy) |
|
Details | ||
| 3/24/2026 | Pfizer | PFE | Maintain | Buy (N/A) |
|
Details | ||
| 3/19/2026 | Johnson & Johnson | JNJ | Maintain | Buy (Buy) |
|
Details | ||
| 3/12/2026 | Abbvie | ABBV | Maintain | Buy (Buy) |
|
Details | ||
| 3/11/2026 | Jade Biosciences | JBIO | Maintain | Buy (N/A) |
|
Details | ||
| 2/6/2026 | Merck | MRK | Maintain | Buy (N/A) |
|
Details | ||
| 2/6/2026 | Amgen | AMGN | Maintain | Neutral (N/A) |
|
Details | ||
| 1/22/2026 | Johnson & Johnson | JNJ | Maintain | Buy (Buy) |
|
Details | ||
| 1/16/2026 | ANI Pharmaceuticals | ANIP | Maintain | Buy (N/A) |
|
Details | ||
| 1/14/2026 | Travere Therapeutics | TVTX | Maintain | Buy (Buy) |
|
Details | ||
| 12/30/2025 | Unicycive Therapeutics | UNCY | Maintain | Buy (Buy) |
|
Details | ||
| 12/17/2025 | Pfizer | PFE | Maintain | Buy (Buy) |
|
Details | ||
| 12/9/2025 | Pfizer | PFE | Maintain | Buy (Buy) |
|
Details | ||
| 12/5/2025 | Johnson & Johnson | JNJ | Maintain | Buy (N/A) |
|
Details | ||
| 12/5/2025 | Merck | MRK | Maintain | Buy (N/A) |
|
Details | ||
| 11/25/2025 | Johnson & Johnson | JNJ | Maintain | Buy (Buy) |
|
Details | ||
| 11/24/2025 | Pfizer | PFE | Maintain | Buy (N/A) |
|
Details | ||
| 11/18/2025 | Eledon Pharamceuticals | ELDN | Maintain | Buy (N/A) |
|
Details | ||
| 11/18/2025 | Jade Biosciences | JBIO | Maintain | Buy (N/A) |
|
Details | ||
| 11/10/2025 | ANI Pharmaceuticals | ANIP | Maintain | Buy (N/A) |
|
Details | ||
| 10/28/2025 | SCYNEXIS | SCYX | Maintain | Buy (N/A) |
|
Details | ||
| 10/20/2025 | Abbvie | ABBV | Maintain | Buy (N/A) |
|
Details | ||
| 10/17/2025 | Johnson & Johnson | JNJ | Maintain | Buy (Buy) |
|
Details | ||
| 10/10/2025 | Pfizer | PFE | Maintain | Buy (Buy) |
|
Details | ||
| 10/8/2025 | Johnson & Johnson | JNJ | Maintain | Buy (Buy) |
|
Details | ||
| 9/30/2025 | Johnson & Johnson | JNJ | Maintain | Buy (Buy) |
|
Details | ||
| 9/23/2025 | Johnson & Johnson | JNJ | Upgrade | Buy (Neutral) |
176.19 (240.87) |
36.71% | Details | |
| 9/10/2025 | Johnson & Johnson | JNJ | Maintain | Neutral (Neutral) |
|
Details | ||
| 9/8/2025 | ANI Pharmaceuticals | ANIP | Maintain | Buy (N/A) |
|
Details | ||
| 9/8/2025 | Assembly Biosciences | ASMB | Maintain | Buy (N/A) |
|
Details | ||
| 9/8/2025 | Insmed | INSM | Maintain | Buy (N/A) |
|
Details | ||
| 8/1/2025 | Abbvie | ABBV | Maintain | Buy (N/A) |
|
Details | ||
| 7/17/2025 | Johnson & Johnson | JNJ | Maintain | Neutral (N/A) |
|
Details | ||
| 7/14/2025 | ProKidney Corp. | PROK | Maintain | Buy (N/A) |
|
Details | ||
| 6/16/2025 | Jade Biosciences | JBIO | Upgrade | Buy (Neutral) |
6.94 (15.34) |
121.04% | Details | |
| 6/6/2025 | Vera Therapeutics | VERA | Maintain | Buy (N/A) |
|
Details | ||
| 6/2/2025 | Vera Therapeutics | VERA | Maintain | Buy (N/A) |
|
Details | ||
| 5/21/2025 | Pfizer | PFE | Maintain | Buy (N/A) |
|
Details | ||
| 5/20/2025 | Amgen | AMGN | New Coverage | Neutral (N/A) |
275.85 (355.20) |
28.77% | Details | |
| 4/30/2025 | Merck | MRK | Maintain | Buy (N/A) |
|
Details | ||
| 4/29/2025 | Abbvie | ABBV | Maintain | Buy (N/A) |
|
Details | ||
| 4/21/2025 | Unicycive Therapeutics | UNCY | New Coverage | Buy (N/A) |
0.60 (7.25) |
1108.33% | Details | |
| 3/25/2025 | Assembly Biosciences | ASMB | New Coverage | Buy (N/A) |
11.12 (22.96) |
106.47% | Details | |
| 3/19/2025 | SCYNEXIS | SCYX | Maintain | Buy (N/A) |
|
Details | ||
| 3/5/2025 | ANI Pharmaceuticals | ANIP | Maintain | Buy (N/A) |
|
Details | ||
| 2/27/2025 | Vera Therapeutics | VERA | Maintain | Buy (N/A) |
|
Details | ||
| 2/12/2025 | Merck | MRK | Maintain | Buy (N/A) |
|
Details | ||
| 2/3/2025 | Abbvie | ABBV | Maintain | Buy (N/A) |
|
Details | ||
| 2/3/2025 | Johnson & Johnson | JNJ | Maintain | Neutral (N/A) |
|
Details | ||
| 1/28/2025 | Eledon Pharamceuticals | ELDN | New Coverage | Buy (N/A) |
4.66 (3.57) |
-23.39% | Details | |
| 1/17/2025 | Merck | MRK | Maintain | Buy (N/A) |
|
Details | ||
| 1/17/2025 | Abbvie | ABBV | Maintain | Buy (N/A) |
|
Details | ||
| 12/16/2024 | Keros Therapeutics | KROS | Downgrade | Neutral (Buy) |
18.43 (10.15) |
-44.93% | Details | |
| 12/11/2024 | Pfizer | PFE | Maintain | Buy (N/A) |
|
Details | ||
| 12/5/2024 | Keros Therapeutics | KROS | Maintain | Buy (N/A) |
|
Details | ||
| 10/2/2024 | Absci Corp. | ABSI | New Coverage | Buy (N/A) |
3.82 (6.80) |
78.01% | Details | |
| 9/23/2024 | Keros Therapeutics | KROS | New Coverage | Buy (N/A) |
57.32 (10.15) |
-82.29% | Details | |
| 9/10/2024 | ProKidney Corp. | PROK | New Coverage | Buy (N/A) |
2.33 (1.64) |
-29.61% | Details | |
| 9/9/2024 | Travere Therapeutics | TVTX | Upgrade | Buy (Neutral) |
10.98 (52.04) |
373.95% | Details | |
| 7/16/2024 | Merck | MRK | New Coverage | Buy (N/A) |
127.76 (119.05) |
-6.82% | Details | |
| 6/17/2024 | Aerovate Therapeutics Inc | AVTE | Downgrade | Neutral (Buy) |
24.62 (2.68) |
-89.11% | Details | |
| 4/11/2024 | Alpine Immune Sciences | ALPN | Downgrade | Neutral (Buy) |
47.04 (64.97) |
38.12% | Details | |
| 4/9/2024 | Alpine Immune Sciences | ALPN | New Coverage | Buy (N/A) |
38.53 (64.97) |
68.62% | Details | |
| 3/27/2024 | Travere Therapeutics | TVTX | Downgrade | Neutral (Buy) |
7.57 (52.04) |
587.45% | Details | |
| 2/23/2024 | Pfizer | PFE | New Coverage | Buy (N/A) |
27.67 (26.21) |
-5.28% | Details | |
| 9/5/2023 | Insmed | INSM | Maintain | Buy (N/A) |
|
Details | ||
| 8/16/2023 | Vera Therapeutics | VERA | New Coverage | Buy (N/A) |
17.80 (34.26) |
92.47% | Details | |
| 8/4/2023 | Travere Therapeutics | TVTX | Maintain | Buy (N/A) |
|
Details | ||
| 7/26/2023 | Insmed | INSM | New Coverage | Buy (N/A) |
20.46 (97.85) |
378.25% | Details | |
| 6/12/2023 | Chinook Therapeutics | KDNY | Downgrade | Neutral (Buy) |
23.99 (40.39) |
68.36% | Details | |
| 4/10/2023 | Travere Therapeutics | TVTX | Maintain | Buy (N/A) |
|
Details | ||
| 4/3/2023 | SCYNEXIS | SCYX | Maintain | Buy (N/A) |
|
Details | ||
| 3/1/2023 | SCYNEXIS | SCYX | New Coverage | Buy (N/A) |
1.47 (4.23) |
187.76% | Details | |
| 3/1/2023 | Gossamer Bio Inc. | GOSS | New Coverage | Neutral (N/A) |
1.76 (0.16) |
-90.91% | Details | |
| 3/1/2023 | ANI Pharmaceuticals | ANIP | New Coverage | Buy (N/A) |
41.83 (81.68) |
95.27% | Details | |
| 3/1/2023 | Calliditas Therapeutics | CALT | New Coverage | Neutral (N/A) |
18.91 (40.00) |
111.53% | Details | |
| 3/1/2023 | Chinook Therapeutics | KDNY | New Coverage | Buy (N/A) |
21.57 (40.39) |
87.25% | Details | |
| 3/1/2023 | Aerovate Therapeutics Inc | AVTE | New Coverage | Buy (N/A) |
24.46 (2.68) |
-89.04% | Details | |
| 3/1/2023 | Johnson & Johnson | JNJ | New Coverage | Neutral (N/A) |
155.63 (176.19) |
13.21% | Details | |
| 3/1/2023 | Abbvie | ABBV | New Coverage | Buy (N/A) |
154.28 (227.73) |
47.61% | Details | |
| 3/1/2023 | Travere Therapeutics | TVTX | New Coverage | Buy (N/A) |
21.74 (52.04) |
139.37% | Details |
